Boston Scientific Corpora... (BSX)
NYSE: BSX
· Real-Time Price · USD
104.16
1.66 (1.62%)
At close: Aug 14, 2025, 3:59 PM
104.23
0.07%
Pre-market: Aug 15, 2025, 07:06 AM EDT
Boston Scientific Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 2.26B | 2.08B | 2.02B | 1.82B | 1.77B | 1.59B | 1.23B | 912M | 902M | 698M | 653M | 884M | 810M | 1.04B | 1.16B | 582M | 248M |
Depreciation & Amortization | 1.62B | 1.6B | 1.56B | 1.23B | 1.22B | 1.2B | 1.18B | 1.16B | 1.15B | 1.14B | 1.13B | 1.12B | 1.1B | 1.09B | 1.09B | 1.1B | 1.11B |
Stock-Based Compensation | 277M | 266M | 256M | 376M | 241M | 233M | 229M | 228M | 223M | 220M | 214M | 207M | 199M | 194M | 187M | 176M | 175M |
Other Working Capital | -290M | -268M | -56M | -61M | -4M | 10M | 46M | -20M | -110M | -209M | -287M | -178M | -146M | -134M | -291M | 62M | -215M |
Other Non-Cash Items | 114M | 23M | -145M | 323M | 229M | 253M | 165M | 347M | 317M | 540M | 717M | 390M | 298M | 17M | 112M | 401M | 485M |
Deferred Income Tax | -60M | -70M | 83M | 65M | 11M | -1M | -67M | -15M | 31M | -63M | -145M | -129M | -198M | -124M | -49M | -116M | -21M |
Change in Working Capital | -397M | -462M | -843M | -1.19B | -990M | -770M | -379M | -507M | -846M | -1B | -1.37B | -1.28B | -680M | -351M | -433M | 98M | -132M |
Operating Cash Flow | 3.81B | 3.44B | 2.94B | 2.63B | 2.48B | 2.5B | 2.35B | 2.13B | 1.77B | 1.53B | 1.2B | 1.19B | 1.53B | 1.87B | 2.06B | 2.24B | 1.87B |
Capital Expenditures | -939M | -997M | -971M | -873M | -924M | -800M | -733M | -699M | -598M | -608M | -674M | -609M | -610M | -554M | -447M | -490M | -479M |
Cash Acquisitions | -4.83B | -4.64B | -2.02B | -887M | -1.48B | -1.81B | -1.02B | -1.09B | -450M | -1.55B | -1.78B | -3.02B | -3.02B | -1.45B | -1.23B | 83M | 92M |
Purchase of Investments | -73M | -139M | -167M | -183M | -173M | -107M | -64M | -70M | -6M | -21M | 15M | 16M | -2M | n/a | -67M | -147M | -157M |
Sales Maturities Of Investments | n/a | n/a | 28M | 43M | 45M | 45M | 87M | 94M | 90M | 122M | 52M | 237M | 323M | 316M | 316M | 109M | 26M |
Other Investing Acitivies | -199M | -118M | -102M | 28M | 93M | 88M | 18M | 27M | 33M | 42M | 103M | 107M | 67M | 95M | 140M | 240M | 254M |
Investing Cash Flow | -5.9B | -5.69B | -3.04B | -1.81B | -2.38B | -2.57B | -1.7B | -1.73B | -921M | -2.01B | -2.29B | -3.27B | -3.24B | -1.6B | -1.28B | -205M | -264M |
Debt Repayment | 458M | 1.83B | 1.64B | 1.57B | 1.61B | -4M | -4M | -118M | -166M | -165M | -165M | -10M | 1M | n/a | -260M | -510M | -1.34B |
Common Stock Repurchased | n/a | 80M | 80M | 80M | 80M | n/a | n/a | n/a | n/a | 52M | 52M | 52M | 52M | 18M | -517M | -517M | -517M |
Dividend Paid | -23M | -23M | -23M | n/a | -14M | -28M | -41M | -55M | -55M | -55M | -55M | -55M | -55M | -55M | -56M | -56M | -42M |
Other Financial Acitivies | -107M | -220M | -219M | -149M | -154M | -82M | -85M | -156M | -474M | -464M | -462M | -417M | -96M | -150M | -157M | -157M | 854M |
Financial Cash Flow | 478M | 1.81B | 1.61B | 1.62B | 1.64B | 5M | -9M | -224M | -611M | -548M | -557M | -352M | -6M | -95M | -906M | -1.16B | -58M |
Net Cash Flow | -1.58B | -449M | 1.52B | 2.44B | 1.73B | -72M | 634M | 164M | 245M | -1.03B | -1.65B | -2.43B | -1.73B | 172M | -126M | 879M | 1.55B |
Free Cash Flow | 2.87B | 2.44B | 1.97B | 1.76B | 1.55B | 1.7B | 1.62B | 1.43B | 1.18B | 918M | 523M | 583M | 918M | 1.32B | 1.62B | 1.75B | 1.39B |